GJB4 variants linked to skin disease exhibit a trafficking deficiency en route to gap junction formation that can be restored by co-expression of select connexins

Epidermal keratinocytes are enriched with at least nine connexins that are key regulators of epidermal homeostasis. The role of Cx30.3 in keratinocytes and epidermal health became evident when fourteen autosomal dominant mutations in the Cx30.3-encoding GJB4 gene were linked to a rare and incurable skin disorder called erythrokeratodermia variabilis et progressiva (EKVP). While these variants are linked to EKVP, they remain largely uncharacterized hindering therapeutic options. In this study, we characterize the expression and functional status of three EKVP-linked Cx30.3 mutants (G12D, T85P, and F189Y) in tissue-relevant and differentiation-competent rat epidermal keratinocytes. We found that GFP-tagged Cx30.3 mutants were non-functional likely due to their impaired trafficking and primary entrapment within the endoplasmic reticulum (ER). However, all mutants failed to increase BiP/GRP78 levels suggesting they were not inducing an unfolded protein response. FLAG-tagged Cx30.3 mutants were also trafficking impaired yet occasionally exhibited some capacity to assemble into gap junctions. The pathological impact of these mutants may extend beyond their trafficking deficiencies as keratinocytes expressing FLAG-tagged Cx30.3 mutants exhibited increased propidium iodide uptake in the absence of divalent cations. Attempts to rescue the delivery of trafficking impaired GFP-tagged Cx30.3 mutants into gap junctions by chemical chaperone treatment were ineffective. However, co-expression of wild type Cx30.3 greatly enhanced the assembly of Cx30.3 mutants into gap junctions, although endogenous levels of Cx30.3 do not appear to prevent the skin pathology found in patients harboring these autosomal dominant mutations. In addition, a spectrum of connexin isoforms (Cx26, Cx30, and Cx43) exhibited the differential ability to trans-dominantly rescue the assembly of GFP-tagged Cx30.3 mutants into gap junctions suggesting a broad range of connexins found in keratinocytes may favourably interact with Cx30.3 mutants. We conclude that selective upregulation of compatible wild type connexins in keratinocytes may have potential therapeutic value in rescuing epidermal defects invoked by Cx30.3 EKVP-linked mutants.

[1]  P. Stathopulos,et al.  The Hydrophobic Residues in Amino Terminal Domains of Cx46 and Cx50 Are Important for Their Gap Junction Channel Ion Permeation and Gating , 2022, International journal of molecular sciences.

[2]  H. Anderton,et al.  Cell death in skin function, inflammation, and disease , 2022, The Biochemical journal.

[3]  D. Laird,et al.  Recent advances in connexin gap junction biology , 2022, Faculty reviews.

[4]  Wei Li,et al.  The Role of Connexin Hemichannels in Inflammatory Diseases , 2022, Biology.

[5]  D. Laird,et al.  Interrogation of Carboxy-Terminus Localized GJA1 Variants Associated with Erythrokeratodermia Variabilis et Progressiva , 2022, International journal of molecular sciences.

[6]  C. Sellitto,et al.  Connexin hemichannel inhibition ameliorates epidermal pathology in a mouse model of keratitis ichthyosis deafness syndrome , 2021, Scientific Reports.

[7]  Xi-lin Zhang,et al.  Erythrokeratodermia variabilis et progressiva due to a novel mutation in GJB4 , 2021, Experimental dermatology.

[8]  D. Laird,et al.  Cellular mechanisms of connexin-based inherited diseases. , 2021, Trends in cell biology.

[9]  S. Reichow,et al.  Connexin 46 and connexin 50 gap junction channel properties are shaped by structural and dynamic features of their N‐terminal domains , 2021, The Journal of physiology.

[10]  I. M. Skerrett,et al.  The Complex and Critical Role of Glycine 12 (G12) in Beta-Connexins of Human Skin , 2021, International journal of molecular sciences.

[11]  J. Shendure,et al.  CADD-Splice—improving genome-wide variant effect prediction using deep learning-derived splice scores , 2021, Genome Medicine.

[12]  Peter B. McGarvey,et al.  UniProt: the universal protein knowledgebase in 2021 , 2020, Nucleic Acids Res..

[13]  J. Sebat,et al.  Inferring the molecular and phenotypic impact of amino acid variants with MutPred2 , 2020, Nature Communications.

[14]  Y. Nishimura,et al.  Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish , 2020, PloS one.

[15]  D. Laird,et al.  Comparative Analysis of Cx31 and Cx43 in Differentiation-Competent Rodent Keratinocytes , 2020, Biomolecules.

[16]  R. Bruzzone,et al.  Connexin hemichannel inhibition improves skin pathology in Clouston syndrome mice , 2020, EBioMedicine.

[17]  F. Mammano,et al.  A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice , 2020, EBioMedicine.

[18]  C. Hetz,et al.  Mechanisms, regulation and functions of the unfolded protein response , 2020, Nature Reviews Molecular Cell Biology.

[19]  D. Laird,et al.  GJB2 Mutations Linked to Hearing Loss Exhibit Differential Trafficking and Functional Defects as Revealed in Cochlear-Relevant Cells , 2020, Frontiers in Cell and Developmental Biology.

[20]  J. Brodsky,et al.  Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators , 2020, International journal of molecular sciences.

[21]  M. Akiyama,et al.  Case of erythrokeratodermia variabilis successfully treated with narrowband ultraviolet B , 2020, Journal of dermatology (Print).

[22]  T. W. White,et al.  Connexin 43 Mutations Lead to Increased Hemichannel Functionality in Skin Disease , 2019, International journal of molecular sciences.

[23]  Zhimiao Lin,et al.  Novel and recurrent mutations in GJB3 and GJB4 cause erythrokeratodermia variabilis et progressiva , 2019, Indian Journal of Dermatology, Venereology and Leprology.

[24]  J. Broers,et al.  A rare missense mutation in GJB3 (Cx31G45E) is associated with a unique cellular phenotype resulting in necrotic cell death , 2019, Experimental dermatology.

[25]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[26]  C. Sellitto,et al.  Connexin43 mutations linked to skin disease have augmented hemichannel activity , 2019, Scientific Reports.

[27]  E. Beyer,et al.  Chemical chaperone treatment improves levels and distributions of connexins in Cx50D47A mouse lenses , 2018, Experimental eye research.

[28]  P. Agostinis,et al.  Endoplasmic reticulum stress signalling – from basic mechanisms to clinical applications , 2018, The FEBS journal.

[29]  C. Naus,et al.  SnapShot: Connexins and Disease , 2017, Cell.

[30]  A. R. Gani,et al.  Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death , 2017, Scientific Reports.

[31]  Donglin Bai,et al.  Patch Clamp Analysis of Gap Junction Channel Properties , 2016 .

[32]  H. Nakagawa,et al.  Japanese sporadic case of erythrokeratodermia variabilis caused by the connexin‐30.3 (GJB4) mutation: Is Glycine 12 a mutational hotspot in the connexin family? , 2016, The Journal of dermatology.

[33]  Akemi Ishida-Yamamoto.  Erythrokeratodermia variabilis et progressiva , 2016, The Journal of dermatology.

[34]  R. Douglas,et al.  Connexin gap junction channels and chronic rhinosinusitis , 2016, International forum of allergy & rhinology.

[35]  C. Sellitto,et al.  Connexin channels in congenital skin disorders. , 2016, Seminars in cell & developmental biology.

[36]  Donglin Bai.  Structural analysis of key gap junction domains--Lessons from genome data and disease-linked mutants. , 2016, Seminars in cell & developmental biology.

[37]  T. Hiragun,et al.  Case of erythrokeratodermia variabilis successfully treated with oral vitamin A , 2015, The Journal of dermatology.

[38]  D. Jagger,et al.  Cx30 exhibits unique characteristics including a long half-life when assembled into gap junctions , 2015, Journal of Cell Science.

[39]  Zhuohua Zhang,et al.  Pathogenic Cx31 is un/misfolded to cause skin abnormality via a Fos/JunB-mediated mechanism. , 2015, Human molecular genetics.

[40]  Martin L. Duennwald.  Cellular stress responses in protein misfolding diseases , 2015, Future science OA.

[41]  Catherine S Wright,et al.  Connexins and pannexins in the integumentary system: the skin and appendages , 2015, Cellular and Molecular Life Sciences.

[42]  D. Laird,et al.  Mechanisms linking connexin mutations to human diseases , 2015, Cell and Tissue Research.

[43]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[44]  T. Tsukihara,et al.  Charge at the 46th residue of connexin 50 is crucial for the gap‐junctional unitary conductance and transjunctional voltage‐dependent gating , 2014, The Journal of physiology.

[45]  M. Hodgins,et al.  Connexins: Sensors of epidermal integrity that are therapeutic targets , 2014, FEBS letters.

[46]  D. Laird,et al.  Mutations in Cx30 that are linked to skin disease and non-syndromic hearing loss exhibit several distinct cellular pathologies , 2014, Journal of Cell Science.

[47]  V. Sim,et al.  The therapeutic potential of chemical chaperones in protein folding diseases , 2014, Prion.

[48]  L. Tao,et al.  Connexin expression patterns in diseased human corneas , 2014, Experimental and therapeutic medicine.

[49]  D. Laird,et al.  Connexin43 Reduces Melanoma Growth within a Keratinocyte Microenvironment and during Tumorigenesis in Vivo* , 2013, The Journal of Biological Chemistry.

[50]  D. Laird,et al.  Gap junction remodeling in skin repair following wounding and disease. , 2013, Physiology.

[51]  C. Bodemer,et al.  Novel mutation in GJB4 gene (connexin 30.3) in a family with erythrokeratodermia variabilis. , 2013, Acta dermato-venereologica.

[52]  D. Kelsell,et al.  Connexins in epidermal homeostasis and skin disease. , 2012, Biochimica et biophysica acta.

[53]  C. Steinhäuser,et al.  Functional redundancy and compensation among members of gap junction protein families? , 2012, Biochimica et biophysica acta.

[54]  Hong Liu,et al.  Mutation analysis of GJB3 and GJB4 in Chinese patients with erythrokeratodermia variabilis , 2012, Journal of dermatology (Print).

[55]  M. Petersen,et al.  Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3. , 2012, European journal of dermatology : EJD.

[56]  Monica A. Chalfant,et al.  Small Molecule Proteostasis Regulators for Protein Conformational Diseases , 2011, Nature chemical biology.

[57]  D. Kelsell,et al.  Novel and recurrent connexin 30.3 and connexin 31 mutations associated with erythrokeratoderma variabilis , 2011, Clinical and experimental dermatology.

[58]  Donglin Bai,et al.  The role of amino terminus of mouse Cx50 in determining transjunctional voltage-dependent gating and unitary conductance. , 2010, Biophysical journal.

[59]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[60]  D. Kelsell,et al.  EKV mutant connexin 31 associated cell death is mediated by ER stress , 2009, Human molecular genetics.

[61]  E. Capriotti,et al.  Functional annotations improve the predictive score of human disease‐related mutations in proteins , 2009, Human mutation.

[62]  So Nakagawa,et al.  Structure of the connexin 26 gap junction channel at 3.5 Å resolution , 2009, Nature.

[63]  A. Oranje,et al.  The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron , 2009, American journal of medical genetics. Part A.

[64]  J. Brandner,et al.  The skin: an indispensable barrier , 2008, Experimental dermatology.

[65]  G. Kidder,et al.  Connexin expression and gap junctional coupling in human cumulus cells: contribution to embryo quality , 2008, Journal of cellular and molecular medicine.

[66]  J. Degen,et al.  Characterization of connexin30.3-deficient mice suggests a possible role of connexin30.3 in olfaction. , 2007, European journal of cell biology.

[67]  Tony Y. Li,et al.  In vivo analysis of undocked connexin43 gap junction hemichannels in ovarian granulosa cells , 2007, Journal of Cell Science.

[68]  G. Richard,et al.  Gap junctions: basic structure and function. , 2007, The Journal of investigative dermatology.

[69]  J. Manias,et al.  Connexin Levels Regulate Keratinocyte Differentiation in the Epidermis* , 2007, Journal of Biological Chemistry.

[70]  D. Laird,et al.  Differentiation of Organotypic Epidermis in the Presence of Skin Disease-Linked Dominant-Negative Cx26 Mutants and Knockdown Cx26 , 2007, Journal of Membrane Biology.

[71]  S. Gallati,et al.  Functional expression of connexin30 and connexin31 in the polarized human airway epithelium. , 2007, Differentiation; research in biological diversity.

[72]  D. Laird,et al.  Functional Characterization of a GJA1 Frameshift Mutation Causing Oculodentodigital Dysplasia and Palmoplantar Keratoderma* , 2006, Journal of Biological Chemistry.

[73]  S. Paul,et al.  Protein‐misfolding diseases and chaperone‐based therapeutic approaches , 2006, The FEBS journal.

[74]  D. Laird,et al.  Life cycle of connexins in health and disease. , 2006, The Biochemical journal.

[75]  Michael Koval.  Pathways and control of connexin oligomerization , 2006, Trends in Cell Biology.

[76]  D. Kelsell,et al.  Clinical and genetic heterogeneity of erythrokeratoderma variabilis. , 2005, The Journal of investigative dermatology.

[77]  D. Laird,et al.  Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration , 2005, Journal of Cell Science.

[78]  K. Xia,et al.  Intracellular distribution, assembly and effect of disease-associated connexin 31 mutants in HeLa cells. , 2005, Acta biochimica et biophysica Sinica.

[79]  G. T. Cottrell,et al.  Functional consequences of heterogeneous gap junction channel formation and its influence in health and disease. , 2005, Biochimica et biophysica acta.

[80]  J. Zieske,et al.  In vivo and in vitro expression of connexins in the human corneal epithelium. , 2005, Investigative ophthalmology & visual science.

[81]  Rainer Schmidt,et al.  The cornified envelope: a model of cell death in the skin , 2005, Nature Reviews Molecular Cell Biology.

[82]  J. Manias,et al.  Functional Characterization of Oculodentodigital Dysplasia-Associated Cx43 Mutants , 2005, Cell communication & adhesion.

[83]  D. Laird,et al.  Rat Epidermal Keratinocytes as an Organotypic Model for Examining the Role of Cx43 and Cx26 in Skin Differentiation , 2005, Cell communication & adhesion.

[84]  G. Crooks,et al.  WebLogo: a sequence logo generator. , 2004, Genome research.

[85]  J. Gemel,et al.  Amino terminal glutamate residues confer spermine sensitivity and affect voltage gating and channel conductance of rat connexin40 gap junctions , 2004, The Journal of physiology.

[86]  K. Willecke,et al.  Gap junctions and the connexin protein family. , 2004, Cardiovascular research.

[87]  P. Meda,et al.  Molecular interaction of connexin 30.3 and connexin 31 suggests a dominant-negative mechanism associated with erythrokeratodermia variabilis. , 2003, Human molecular genetics.

[88]  S. Bale,et al.  Genetic heterogeneity in erythrokeratodermia variabilis: novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations. , 2003, The Journal of investigative dermatology.

[89]  D. Kelsell,et al.  Defective trafficking and cell death is characteristic of skin disease-associated connexin 31 mutations. , 2002, Human molecular genetics.

[90]  D. Kelsell,et al.  Multiple epidermal connexins are expressed in different keratinocyte subpopulations including connexin 31. , 2001, The Journal of investigative dermatology.

[91]  D. Hohl,et al.  Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. , 2000, American journal of human genetics.

[92]  P. Cartlidge,et al.  The epidermal barrier. , 2000, Seminars in neonatology : SN.

[93]  G. Richard,et al.  Connexins: a connection with the skin , 2000, Experimental dermatology.

[94]  C. Naus,et al.  Connexins and Disease , 1996, Science.

[95]  R. Bruzzone,et al.  Multiple connexin proteins in single intercellular channels: Connexin compatibility and functional consequences , 1996, Journal of bioenergetics and biomembranes.

[96]  K. Willecke,et al.  Two gap junction genes, connexin 31.1 and 30.3, are closely linked on mouse chromosome 4 and preferentially expressed in skin. , 1992, The Journal of biological chemistry.

[97]  T. D. Schneider,et al.  Sequence logos: a new way to display consensus sequences. , 1990, Nucleic acids research.

[98]  H. Aoyama,et al.  Crucial motifs and residues in the extracellular loops influence the formation and specificity of connexin docking. , 2018, Biochimica et biophysica acta. Biomembranes.

[99]  T. W. White,et al.  Human diseases associated with connexin mutations. , 2018, Biochimica et biophysica acta. Biomembranes.

[100]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[101]  D. Paul,et al.  Gap junctions. , 2009, Cold Spring Harbor perspectives in biology.

[102]  G. Richard.  Connexin disorders of the skin. , 2005, Clinical Dermatology.

[103]  M. Yeager,et al.  Structure and biochemistry of gap junctions , 2000 .